Delivering What Matters to Biopharma
GCP ClinPlus is a trusted CRO partner for respiratory drug and device development, offering end-to-end, scalable solutions tailored to the unique needs of respiratory clinical trials.
We specialize in the full spectrum of pulmonary and upper airway conditions, including acute and chronic sinusitis, allergic rhinitis (seasonal and perennial), asthma (mild to severe), COPD, cystic fibrosis, emphysema, idiopathic pulmonary fibrosis (IPF), and respiratory-related cancers.
Our strengths in respiratory clinical research include:
Customizable trial designs and biomarker-driven protocols tailored to complex endpoints
Agile operational models for fast, adaptive project implementation
Efficient study start-up and accelerated recruitment supported by a nationwide network of specialized sites
Dedicated respiratory research teams, ensuring continuous, expert support across all trial phases
With more than 100 respiratory trials completed, we've helped sponsors—from emerging biotechs to global pharma—navigate regulatory pathways, optimize study execution, and bring respiratory innovations to patients faster.
